Hikma Pharmaceuticals plc (HIK)
HIK · Health Care · 
United Kingdom
Hikma Pharmaceuticals plc (HIK) is a British company in the Health Care sector. The stock has its largest weight in ZPD3 (S&P Global Dividend Aristocrats), at 0.74%. Anyone who holds an ETF containing Hikma Pharmaceuticals also has an indirect stake in the company.
Data and Charts: Hikma Pharmaceuticals
Key Data for Hikma Pharmaceuticals
Alysly Data Analysis: Hikma Pharmaceuticals
What ETF Is Hikma Pharmaceuticals In?
Hikma Pharmaceuticals has above-average ETF coverage and is held by 16 of the 104 ETFs we track, which together follow 6 indices. That puts the stock in more ETFs than 76.8% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| ZPD3 | S&P Global Dividend Aristocrats | 0.74% | €7.41 |
| SMC | MSCI Europe Small Cap | 0.22% | €2.17 |
| XXSC / XMES | MSCI Europe Small Cap | 0.21% | €2.14 |
| XSWC / XSWD | MSCI World Small Cap | 0.03% | €0.30 |
| ZPRS / WDSD | MSCI World Small Cap | 0.03% | €0.25 |
| XSX6 / XSX7 | STOXX Europe 600 | 0.02% | €0.25 |
| X600 / XESU | STOXX Europe 600 | 0.02% | €0.23 |
| EXSA | STOXX Europe 600 | 0.02% | €0.20 |
| WIMI | MSCI World IMI | 0.01% | €0.08 |
| SPYI / SPSA | MSCI ACWI IMI | < 0.01% | < €0.05 |
The last column shows how much of €1,000 in one of these funds goes to Hikma Pharmaceuticals, based on each fund's latest holdings list.
US-listed ETFs holding Hikma Pharmaceuticals (weight per latest SEC filing): VXUS 0.01%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
Hikma Pharmaceuticals Weight in iShares STOXX Europe 600 (EXSA) Since 2019
In iShares STOXX Europe 600 (EXSA), Hikma Pharmaceuticals had a weight of 0.04% on Sep 30, 2019 and 0.02% on Oct 30, 2026. The fund tracks the STOXX Europe 600. Its share peaked at 0.06% on Sep 30, 2020. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Hikma Pharmaceuticals overlaps with the rest of a portfolio.
Stocks With ETF Exposure Similar to Hikma Pharmaceuticals
| Stock | Shared ETFs | r |
|---|---|---|
| Hikma Pharmaceuticals | – | – |
| Londonmetric Property | 16 | – |
| A2A S.p.A. | 16 | – |
| Cembra Money Bank | 16 | – |
| Valmet | 16 | – |
| Convatec Group | 15 | – |
| ALK-abello A/S | 15 | – |
| Galenica | 15 | – |
| Getinge | 15 | – |
These stocks reach a portfolio through largely the same funds as Hikma Pharmaceuticals. “Shared ETFs” counts the funds that hold both.
